Startup · $94m raised
Sydney, NSW
Every investor coverage indicates participated in a round All G raised.
| Investor | Rounds | Invested |
|---|---|---|
| Woolworths | Unnamed stage | - |
| Peter Andrews | Seed | - |
| NSW Government | Grant | - |
| ID Capital | Bridge / extension | - |
| Ellerston Capital | Seed | - |
| Döhler Ventures | Bridge / extension | - |
| Doehler | Bridge / extension | - |
| Clean Energy Innovation Fund | Seed | - |
| Agronomics | Grant · Bridge / extension · Unnamed stage | $28,000,000 |
Investors whose own portfolio pages list All G, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Virescent Ventures | its portfolio page ↗ |
Companies All G acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Guillaume Barbier | Chief Technology Officer | FaBA |
| Jan Pacas | CEO · Founder | AgFunderNews (23 Jul 2026), Startup Daily (12 Dec 2025), SmartCompany, Startup Daily (9 Dec 2025), AgFunderNews (8 Dec 2025), Startup Daily (15 Jul 2025) |
Stories naming All G. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Interview with Eclipse Ingredients' chief executive on commercialising human lactoferrin through precision fermentation, beginning with cosmetics, plus its distributor agreements and partnerships for manufacturing scale-up.
AgFunderNews roundup of agrifood funding raises, executive appointments, shutdowns and partnerships, including Ranchbot's Series B, ClimateAi and Cultimate shutting down, and Novonesis seeking sole control of MicroBioGen.
Australian food-tech firm All G has launched a low-iron, fermentation-derived lactoferrin in the US, producing multiple tonnes yearly via a Chinese manufacturer, with European capacity and a human-equivalent version planned.
NSW's government is lending startups money to commercialise research via a new repayable fund, and names biotech and RNA grant recipients while reopening a ventures grants round.
NSW has launched a $20m fund to help startups commercialise emerging tech and named All G, HydGene Renewables, Number 8 Bio and Swan Genomics as recipients of Biosciences Fund grants.
Also Startup Daily
Weekly agtech and foodtech roundup: several startup raises, BASF's purchase of AgBiTech, three new funds, a Bühler CEO appointment, Microsoft carbon-credit deals, and company shutdowns.
Funding roundup led by Airwallex's US$330 million Series G at a $12 billion valuation, with raises from Kasada, Hnry, All G, Bless Payments and Emanda, plus earlier rounds recalled.
Also Startup Daily
Sydney biotech All G raised $10 million via convertible note from Agronomics, Doehler's venture arm and ID Capital, alongside a joint venture with France's Armor Protéines to push its fermented lactoferrin products globally.
Precision fermentation startup All G banked A$10 million through a convertible note and teamed up with French dairy ingredients maker Armor Protéines to sell lactoferrin, targeting a first product launch in early 2026.
FaBA's accelerator program has handed a University of Queensland precision-fermentation dairy process to Sydney startup All G, which will scale it toward a milk supplement, with federal government support.
Animal-free cheese maker Change Foods has closed an oversubscribed seed round totalling $21.5 million, led by Route 66 Ventures with Giant Leap and angels, alongside collaboration deals with Upfield and Sigma.
Also @AuManufacturing·Startup Daily·SmartCompany·Startup Daily·@AuManufacturing